Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ryan

Showing results (571-580 of 649) with videos related to

Pageof 65
Sort By:
Journal of Clinical Immunology|May 28, 2004
Direct measurement of peptide-specific CD8+ T cells using HLA-A2:Ig dimer for monitoring the in vivo immune response to a HER2/neu vaccine in breast and prostate cancer patientsMichael M Woll, Christine M Fisher, Gayle B Ryan, et al.
Cancers|July 14, 2023
Efficacy of a HER2-Targeted Thorium-227 Conjugate in a HER2-Positive Breast Cancer Bone Metastasis ModelJenny Karlsson, Urs B Hagemann, Véronique Cruciani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Synergistic Effect of a Mesothelin-Targeted <sup>227</sup>Th Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft ModelsKatrine Wickstroem, Urs B Hagemann, Véronique Cruciani, et al.
Epilepsia|July 7, 2017
Risk of angioedema associated with levetiracetam compared with phenytoin: Findings of the observational health data sciences and informatics research networkJon D Duke, Patrick B Ryan, Marc A Suchard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Phase I clinical trial of a HER-2/neu peptide (E75) vaccine for the prevention of prostate-specific antigen recurrence in high-risk prostate cancer patientsMatthew T Hueman, Zia A Dehqanzada, Thomas E Novak, et al.
Pharmacoepidemiology and Drug Safety|August 29, 2019
Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databasesLu Wang, Erica A Voss, James Weaver, et al.
Environmental Pollution (Barking, Essex : 1987)|December 3, 2014
Predicting exposure of wildlife in radionuclide contaminated wetland ecosystemsK Stark, P Andersson, N A Beresford, et al.
Pharmacoepidemiology and Drug Safety|October 9, 2025
Recommendations to Enable Broader Use of Real-World Evidence to Inform Decision-Making Throughout Pharmacovigilance Signal ManagementG Niklas Norén, Katherine Donegan, Monica A Muñoz, et al.
Hypertension (Dallas, Tex. : 1979)|March 29, 2021
Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients: A Large-Scale Multicenter Observational StudySeng Chan You, Harlan M Krumholz, Marc A Suchard, et al.
Drug Safety|June 16, 2023
Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety SurveillanceFaaizah Arshad, Martijn J Schuemie, Fan Bu, et al.
Pageof 65

Showing results (571-580 of 649) with videos related to

Sort By:
Pageof 65
Journal of Clinical Immunology|May 28, 2004
Direct measurement of peptide-specific CD8+ T cells using HLA-A2:Ig dimer for monitoring the in vivo immune response to a HER2/neu vaccine in breast and prostate cancer patientsMichael M Woll, Christine M Fisher, Gayle B Ryan, et al.
Cancers|July 14, 2023
Efficacy of a HER2-Targeted Thorium-227 Conjugate in a HER2-Positive Breast Cancer Bone Metastasis ModelJenny Karlsson, Urs B Hagemann, Véronique Cruciani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Synergistic Effect of a Mesothelin-Targeted <sup>227</sup>Th Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft ModelsKatrine Wickstroem, Urs B Hagemann, Véronique Cruciani, et al.
Epilepsia|July 7, 2017
Risk of angioedema associated with levetiracetam compared with phenytoin: Findings of the observational health data sciences and informatics research networkJon D Duke, Patrick B Ryan, Marc A Suchard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Phase I clinical trial of a HER-2/neu peptide (E75) vaccine for the prevention of prostate-specific antigen recurrence in high-risk prostate cancer patientsMatthew T Hueman, Zia A Dehqanzada, Thomas E Novak, et al.
Pharmacoepidemiology and Drug Safety|August 29, 2019
Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databasesLu Wang, Erica A Voss, James Weaver, et al.
Environmental Pollution (Barking, Essex : 1987)|December 3, 2014
Predicting exposure of wildlife in radionuclide contaminated wetland ecosystemsK Stark, P Andersson, N A Beresford, et al.
Pharmacoepidemiology and Drug Safety|October 9, 2025
Recommendations to Enable Broader Use of Real-World Evidence to Inform Decision-Making Throughout Pharmacovigilance Signal ManagementG Niklas Norén, Katherine Donegan, Monica A Muñoz, et al.
Hypertension (Dallas, Tex. : 1979)|March 29, 2021
Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients: A Large-Scale Multicenter Observational StudySeng Chan You, Harlan M Krumholz, Marc A Suchard, et al.
Drug Safety|June 16, 2023
Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety SurveillanceFaaizah Arshad, Martijn J Schuemie, Fan Bu, et al.
Pageof 65